Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines.
about
Structures of lactate dehydrogenase A (LDHA) in apo, ternary and inhibitor-bound formsReexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg effectAdipose tissue dysfunction and its effects on tumor metabolismDifferent effects of LDH-A inhibition by oxamate in non-small cell lung cancer cellsHuman hepatocellular carcinoma in a mouse model: assessment of tumor response to percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonistsA comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line modelsAnticancer agents that counteract tumor glycolysis.Dual targeting of the Warburg effect with a glucose-conjugated lactate dehydrogenase inhibitor.Small-molecule inhibitors of human LDH5.Targeting Metabolic Remodeling in Triple Negative Breast Cancer in a Murine Model.Glyceraldehyde-3-phosphate dehydrogenase: a promising target for molecular therapy in hepatocellular carcinomaTaming Tumor Glycolysis and Potential Implications for Immunotherapy.Galloflavin (CAS 568-80-9): a novel inhibitor of lactate dehydrogenase.Transformation by different oncogenes relies on specific metabolic adaptations.Perspective on the dynamics of cancer.Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy.Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment.
P2860
Q27697939-F76F5FDE-E833-4257-8E62-10E85C19539DQ28077883-8981E0AB-3DEF-4568-B868-2C8BF5A25D81Q28080748-229C8E71-610F-4734-984D-EF2B2601BB20Q35068068-2BE31A7E-D593-4A04-8A88-F21986E1B8B2Q35773581-DD19E5D2-01E5-46F6-A77F-422E09A590BBQ36413261-C42217C5-EBB1-4483-B200-518F088377ADQ36452381-0BCD82EF-0458-4A5E-BED0-7E7A5CF986BEQ37575221-9227EDA0-7912-4913-BEEB-B09EA56FDDBDQ37634356-0B560BD1-E60C-4A84-9210-C28898F3DB7BQ37667761-DA8E178A-F72E-4953-BCCD-F6741B0CF022Q38042261-01AB7798-6BFE-4BC3-AF95-E7FE16FA0530Q38872235-CE27DB57-4A9F-4B1A-A121-92AD1CEFDDA2Q39448204-53C8430D-2466-49DA-BA6A-5CFD3F0AE398Q41352726-A8E829DA-69C4-4C4E-897E-724EFEB8EFF1Q42284422-41758AE5-61CA-4964-8835-DCFF3FE50B83Q52661722-1CDC0A83-F949-424B-BB74-390B7752E299Q55396364-A8A45524-CD6F-43F3-B3D2-DA2087AA2726
P2860
Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Impairment of aerobic glycolys ...... cellular carcinoma cell lines.
@en
Impairment of aerobic glycolys ...... cellular carcinoma cell lines.
@nl
type
label
Impairment of aerobic glycolys ...... cellular carcinoma cell lines.
@en
Impairment of aerobic glycolys ...... cellular carcinoma cell lines.
@nl
prefLabel
Impairment of aerobic glycolys ...... cellular carcinoma cell lines.
@en
Impairment of aerobic glycolys ...... cellular carcinoma cell lines.
@nl
P356
P1433
P1476
Impairment of aerobic glycolys ...... ocellular carcinoma cell lines
@en
P2093
Luigi Fiume
Marina Vettraino
P304
P356
10.1159/000317519
P577
2010-08-10T00:00:00Z